相关实验视频

Updated: Jun 4, 2025

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

推进莱什曼病治疗:从克服挑战到接受治疗创新

Vishal Kumar Singh¹, Rahul Tiwari¹, Rajneesh¹

¹Centre of Experimental Medicine and Surgery, Institute of Medical Sciences Banaras Hindu University, Varanasi-221005, U.P., India.

ACS infectious diseases

|December 31, 2024

概括

莱什曼病的治疗面临着药物耐药性和毒性的挑战. 迫切需要新的治疗目标和创新策略,以开发有效的抗莱什曼治疗方法.

科学领域:

寄生虫学的寄生虫学
热带医学热带医学
药物发现药物发现药物发现

背景情况:

莱什曼病在热带和亚热带地区构成重大公共卫生威胁,影响社会经济因素.
目前对莱什曼病的药物治疗受到毒性,成本和新兴药物耐药性的限制.
由于缺乏有效的疫苗,需要改进治疗干预措施.

研究的目的:

突出在莱什曼病治疗中迫切需要新的治疗点.
为了探索寄生虫的生命周期和巨细胞的生存,寻找潜在的干预点.
讨论当前抗莱什曼病药物的局限性以及改善治疗方法的需要.

主要方法:

审查目前的莱什曼病治疗局限性和挑战.
对Leishmania寄生虫的生命周期和宿主-病原体相互作用的分析.
在寄生虫生理学中探索潜在的新型治疗点.

主要成果:

现有的治疗方法,如抗金质药物,安福特乙和米尔特福辛,表现出显著的限制.
药物耐药性和不良副作用是当前利什曼病药物的主要问题.
了解寄生虫生物学为识别新的药物点提供了途径.

结论:

新的治疗点,如必需的寄生虫酶或表面蛋白质,对于开发更好的莱什曼病药物至关重要.
创新方法,包括药物重新使用,组合疗法和纳米技术,对于提高治疗效率和克服耐药性至关重要.
改进的抗莱什曼病疗法对于打击全球莱什曼病负担至关重要.

关键词:

化疗干预的化学疗法干预莱什曼尼亚的捐赠人莱什曼病是一种莱什曼病.生命周期生命周期原生动物疾病原生动物疾病.治疗目标治疗目标替代药物治疗方法的方法

更多相关视频

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...